等待开盘 04-03 09:30:00 美东时间
-0.120
-5.36%
Firefly Neuroscience (NASDAQ:AIFF) reported quarterly losses of $(0.15) per share. This is a 66.67 percent increase over losses of $(0.45) per share from the same period last year. The company reported $412.000 thousand
04-01 06:47
Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service MembersPartnership Represents a Significant Expansion of Company's Commercial
03-26 19:49
Gainers Firefly Neuroscience (NASDAQ:AIFF) stock rose 25.5% to $1.92 during Fr...
03-21 05:05
Firefly Neuroscience shares are trading higher Friday after it advanced research using its Evoke System to help distinguish ADHD subtypes.
03-14 03:15
Entry into a Material Definitive Agreement. On March 8, 2026, Firefly Neuroscience, Inc., a Delaware corporation (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with
03-13 05:10
Firefly Neuroscience stock climbs after a major expansion in brain scan partnerships and rapid growth in its EEG data network.
03-07 01:07
Firefly Neuroscience Inc's (NYSE:AIFF) short interest as a percent of float has...
03-07 00:00
Gainers Impact BioMedical (AMEX:IBO) shares rose 70.2% to $0.7 during Thursday...
03-05 20:05
- Company reports 20-fold expansion of commercial footprint, 33-fold increase in EEG/ERP brain scan volumes - - Harnessing increased data and cutting-edge supercomputing potentially unlocks new AI-driven biomarker
03-04 20:47
Gainers Imunon (NASDAQ:IMNN) shares increased by 8.8% to $3.6 during Wednesday...
2025-12-25 05:05